Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange shareholders to decide on dividends on May 31

4/26/24 MOEX

Seligdar found a way to improve Kuchus' performance

4/26/24 SELG

Lukoil reports for 3 months of 2024 by RAS

4/26/24 LKOH

Cian has reported for 2023

4/26/24 CIAN

Ingrad reported for 2023 by IFRS

4/26/24 INGR

Shareholders of LUKOIL approved dividends for 2023

4/26/24 LKOH

DIOD reported for 3 months of 2024 by RAS

4/26/24 DIOD

Positive Technologies reported for 3 months of 2024 by IFRS

4/26/24 POSI

Positive Technologies' shipment volume in Q1 grew by 49%

4/26/24 POSI

VSPMO-AVISMA reported for 2023 by IFRS

4/26/24 VSMO